65,437 trials
Osteoarthritis
Primary: Kaplan-Meier Estimate: Overall Survivorship of POLARSTEM — 100; 99.6; 99.1; 98.7 percentage of hips
Healthy Participants
Primary: Aspart Concentration-time Curve From 0 to 12 Hours Area Under the Insulin Aspart Concentration-Time Curve (AUC0-t). — 894.971; 899.163; 904.131 min*ng/ml
Colorectal Neoplasms · Trifluridine and Tipiracil · Circulating Tumor DNA
Primary: Disease-free Survival 1 (DFS1) — 9.30; 5.55 Months
Prosthesis User · Amputation
Primary: Timed Up and Go Test (TUG Test) — 13.3; 16.8 seconds
Rheumatoid Arthritis · Cardiovascular Disease
Primary: Coronary Flow Reserve — 2.65 ratio
Paroxysmal Atrial Fibrillation
Primary: Number of Participants Safety Event-free at 12 Months Post Procedure — 368 Number of Participants
Healthy
Primary: Mass Balance and Total Recovery of [14C]-Radioactivity in Urine: Fraction of [14C]-Radioactivity Excreted in Urine Expressed as Percentage of the Administered Dose Over…
Cataract · Corneal Astigmatism
Primary: Mean Magnitude of Residual Manifest Cylinder — -0.368; -0.780 Diopters
Obesity
Primary: Acceptability — 4.6; 4.2 score
Coronary Artery Bypass Graft · CABG
Primary: Inspiratory Muscle Function — 46.4; 52.8; 68.8; 50.0 cm H2O
Intervertebral Disc Degeneration
Primary: Change (Preop-postop) of Disability, Oswestry Disability Index (ODI) at 3 Months as Compared to Baseline in DDD Patients With Spondylolisthesis — 23.19; 26.08 change of…
Cystic Fibrosis · Cystic Fibrosis-related Diabetes
Primary: Weight — -4.6 kilograms
Obesity
Primary: Hyperpalatable Food Intake — 325.95; 262.51 kilocalories
Gastrointestinal Stromal Tumors
Primary: Proportion of Participants With Best Overall Response at Month 6 (Core Phase) Determined According to the RECIST v1.0. — 0; 14; 21; 6 Participants
Acute Myeloid Leukemia · Fatigue
Primary: Fatigue Score on the Tang Fatigue Rating Scale (TFRS) . — 106.96; 128.46 scores